HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jesper Swedenborg Selected Research

inogatran

3/2004Inhibition of neointimal hyperplasia by a specific thrombin inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jesper Swedenborg Research Topics

Disease

13Aneurysm (Aneurysms)
11/2015 - 12/2003
13Abdominal Aortic Aneurysm
11/2015 - 07/2005
12Thrombosis (Thrombus)
11/2015 - 12/2003
6Atherosclerosis
08/2012 - 07/2003
4Rupture
08/2011 - 01/2005
2Cardiovascular Diseases (Cardiovascular Disease)
07/2015 - 08/2010
2Peripheral Arterial Disease
07/2015 - 08/2011
2Atherosclerotic Plaque (Atheroma)
05/2006 - 01/2005
1Type 2 Diabetes Mellitus (MODY)
07/2015
1Hypertension (High Blood Pressure)
08/2011
1Breast Neoplasms (Breast Cancer)
08/2011
1Myocardial Infarction
08/2011
1Stroke (Strokes)
04/2011
1Amaurosis Fugax
04/2011
1Transient Ischemic Attack
04/2011
1Asthma (Bronchial Asthma)
12/2010
1Fatigue
07/2008
1Chronic Limb-Threatening Ischemia
05/2008
1Inflammation (Inflammations)
02/2007
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2005
1Vascular System Injuries
03/2004
1Neointima
03/2004
1Hyperplasia
03/2004
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2003
1Thrombophilia
03/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
10/2014 - 07/2005
6Messenger RNA (mRNA)IBA
08/2012 - 05/2006
6Phenobarbital (Luminal)FDA Link
01/2012 - 03/2004
4Matrix Metalloproteinases (MMPs)IBA
10/2014 - 07/2005
3Peptide Hydrolases (Proteases)FDA Link
11/2015 - 07/2005
3AntithrombinsIBA
03/2004 - 03/2002
2EnzymesIBA
10/2014 - 12/2010
2ElastinIBA
10/2014 - 12/2003
2ElementsIBA
08/2011 - 07/2008
2Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
12/2010 - 05/2006
25-Lipoxygenase-Activating ProteinsIBA
12/2010 - 05/2006
2LeukotrienesIBA
12/2010 - 05/2006
2LipidsIBA
08/2010 - 05/2006
2GelatinasesIBA
11/2006 - 07/2005
2ThrombinFDA Link
03/2004 - 03/2002
1S100A12 ProteinIBA
07/2015
1N(6)-carboxymethyllysine (carboxymethyllysine)IBA
07/2015
1Receptor for Advanced Glycation End ProductsIBA
07/2015
1Cathepsin KIBA
10/2014
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
08/2012
1CollagenIBA
08/2012
1Biomarkers (Surrogate Marker)IBA
08/2012
1Contraceptive Agents (Contraceptives)IBA
08/2011
1Estrogens (Estrogen)FDA Link
08/2011
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2011
1N 30IBA
04/2011
1Biological ProductsIBA
04/2011
1PlasminogenIBA
04/2011
1FibrinIBA
04/2011
1Leukotriene C4IBA
12/2010
1ThromboxanesIBA
08/2010
1PerforinIBA
02/2010
1Apolipoproteins E (ApoE)IBA
02/2010
1ApolipoproteinsIBA
02/2010
1Angiotensin IIIBA
02/2010
1Granzymes (Granzyme)IBA
02/2010
1Anti-Bacterial Agents (Antibiotics)IBA
07/2008
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
07/2008
1Bovine Serum AlbuminIBA
07/2008
1Lipocalin-2IBA
08/2007
1Heparitin Sulfate (Heparan Sulfate)IBA
02/2007
1Lipoproteins (Lipoprotein)IBA
02/2007
1perlecanIBA
02/2007
1Leukotriene B4IBA
05/2006
1leukotriene A4 hydrolaseIBA
05/2006
1Antiphospholipid AntibodiesIBA
01/2005
1AntibodiesIBA
01/2005
1Annexin A5IBA
01/2005
1inogatranIBA
03/2004
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2003
1oxidized low density lipoproteinIBA
07/2003
1Fibrinogen (Factor I)FDA Link
03/2002
1Prothrombin (Factor II)IBA
03/2002
1fibrin fragment D (D-dimer)IBA
03/2002

Therapy/Procedure

2Surgical Amputation (Amputations)
07/2015 - 05/2008
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
08/2011
1Vascular Surgical Procedures
08/2011
1Gynecologic Surgical Procedures (Gynecologic Surgery)
08/2011